Market News

TCS Share Price Live Updates: TCS's beta of 0.4044 highlights low market risk

Tata Motors PV Share Price Live Updates: Tata Motors PV's beta indicates potential for higher returns

Tata Steel Share Price Live Updates: Tata Steel's six-month beta reflects stability

Wipro Share Price Live Updates: Wipro's low beta signals investor confidence

FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market

Wockhardt’s newly approved antibiotic Zaynich has the potential to transform the treatment of drug-resistant infections, according to Mahesh Patel, the scientist behind the drug. Approved by the US FDA for complicated urinary tract infections, Zaynich combines cefepime and zidebactam, using a novel “beta-lactam enhancer” mechanism that blocks two key steps in bacterial cell-wall synthesis, helping it overcome virtually all known resistance mechanisms.

Wipro Share Price Live Updates: Wipro's beta indicates a defensive stock

LTIMindtree Share Price Live Updates: LTIMindtree's beta value points to consistent performance

Tata Steel Share Price Live Updates: Tata Steel's market behavior analyzed through beta

HCL Tech Share Price Live Updates: HCL Tech's beta indicates market resilience

Tata Motors PV Share Price Live Updates: Tata Motors PV showcases high beta value

Tata Consumer Share Price Live Updates: Tata Consumer's beta insights

Infosys Share Price Live Updates: Infosys's beta indicates a stable investment